Astera Labs (NASDAQ:ALAB) Coverage Initiated at Citigroup

Equities research analysts at Citigroup started coverage on shares of Astera Labs (NASDAQ:ALAB) in a research note issued to investors on Thursday. The brokerage set a “buy” rating and a $200.00 price target on the stock. Citigroup’s price objective would indicate a potential upside of 86.62% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Loop Capital initiated coverage on shares of Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price for the company. Morgan Stanley reiterated an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Northland Securities lifted their target price on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $199.44.

Astera Labs Price Performance

Shares of NASDAQ ALAB traded up $0.84 during mid-day trading on Thursday, reaching $107.17. 295,999 shares of the company traded hands, compared to its average volume of 5,097,899. The firm has a market cap of $18.35 billion, a PE ratio of 87.33, a price-to-earnings-growth ratio of 2.16 and a beta of 1.78. Astera Labs has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a fifty day simple moving average of $133.79 and a 200-day simple moving average of $160.73.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same period last year, the company posted $0.37 EPS. The firm’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts predict that Astera Labs will post 0.34 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the sale, the chief financial officer owned 192,083 shares of the company’s stock, valued at $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00. Following the transaction, the general counsel directly owned 128,084 shares in the company, valued at approximately $15,046,027.48. This represents a 7.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 384,292 shares of company stock valued at $48,724,919. Corporate insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Nordea Investment Management AB bought a new position in Astera Labs in the 4th quarter worth approximately $2,028,000. Geneva Partners LLC bought a new position in Astera Labs during the third quarter worth $1,876,000. Numerai GP LLC raised its stake in Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares during the last quarter. Handelsbanken Fonder AB boosted its holdings in Astera Labs by 289.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after purchasing an additional 93,800 shares during the period. Finally, Corient Private Wealth LLC acquired a new stake in Astera Labs in the 2nd quarter worth $543,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.